Samuel Lockhart to Fluorodeoxyglucose F18
This is a "connection" page, showing publications Samuel Lockhart has written about Fluorodeoxyglucose F18.
Connection Strength
0.299
-
Lockhart SN, Ayakta N, Winer JR, La Joie R, Rabinovici GD, Jagust WJ. Elevated 18F-AV-1451 PET tracer uptake detected in incidental imaging findings. Neurology. 2017 03 14; 88(11):1095-1097.
Score: 0.146
-
Li L, Kang J, Lockhart SN, Adams J, Jagust WJ. Spatially Adaptive Varying Correlation Analysis for Multimodal Neuroimaging Data. IEEE Trans Med Imaging. 2019 01; 38(1):113-123.
Score: 0.040
-
Cho SH, Shin JH, Jang H, Park S, Kim HJ, Kim SE, Kim SJ, Kim Y, Lee JS, Na DL, Lockhart SN, Rabinovici GD, Seong JK, Seo SW. Amyloid involvement in subcortical regions predicts cognitive decline. Eur J Nucl Med Mol Imaging. 2018 12; 45(13):2368-2376.
Score: 0.040
-
Schreiber S, Schreiber F, Lockhart SN, Horng A, Bejanin A, Landau SM, Jagust WJ. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology. JAMA Neurol. 2017 06 01; 74(6):650-659.
Score: 0.037
-
Ossenkoppele R, Schonhaut DR, Schöll M, Lockhart SN, Ayakta N, Baker SL, O'Neil JP, Janabi M, Lazaris A, Cantwell A, Vogel J, Santos M, Miller ZA, Bettcher BM, Vossel KA, Kramer JH, Gorno-Tempini ML, Miller BL, Jagust WJ, Rabinovici GD. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. Brain. 2016 05; 139(Pt 5):1551-67.
Score: 0.034